Company news

Vogenx Inc news in 2026

Vogenx Inc's news releases, calls and decks from 2026, newest first.

View company

Vogenx Initiates Phase 2b EMERGE Study of Mizagliflozin for Post-Bariatric Hypoglycemia

October 15, 2026

Vogenx Appoints Board Member Richard Gorman as Chief Commercial Officer

October 9, 2026

Vogenx Announces Closing of Initial Public Offering

August 13, 2026

Decks in 2026